|
RPL36 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79167791714008E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.45979952757148E-11 |
| Normal-vs-Stage2 |
3.645900E-04 |
| Normal-vs-Stage3 |
2.07029999998998E-05 |
| Normal-vs-Stage4 |
1.238540E-03 |
| Stage1-vs-Stage2 |
9.953600E-01 |
| Stage1-vs-Stage3 |
4.159000E-01 |
| Stage1-vs-Stage4 |
4.229600E-04 |
| Stage2-vs-Stage3 |
5.441600E-01 |
| Stage2-vs-Stage4 |
2.938000E-02 |
| Stage3-vs-Stage4 |
1.760240E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.84574577843932E-12 |
| Normal-vs-AfricanAmerican |
5.32060000502099E-08 |
| Normal-vs-Asian |
9.435900E-02 |
| Caucasian-vs-AfricanAmerican |
8.148800E-01 |
| Caucasian-vs-Asian |
8.710200E-01 |
| AfricanAmerican-vs-Asian |
9.355600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.82485146385625E-12 |
| Normal-vs-Female |
1.15210000428689E-08 |
| Male-vs-Female |
3.409600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.92059999998473E-06 |
| Normal-vs-Extreme_Weight |
6.51922960059892E-13 |
| Normal-vs-Obese |
1.68339999717659E-08 |
| Normal-vs-Extreme_Obese |
3.077800E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.189800E-01 |
| Normal_Weight-vs-Obese |
6.066200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.554600E-01 |
| Extreme_Weight-vs-Obese |
8.975600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.976600E-01 |
| Obese-vs-Extreme_Obese |
4.195000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63885999999724E-05 |
| Normal-vs-Age(41-60Yrs) |
1.92880045268851E-10 |
| Normal-vs-Age(61-80Yrs) |
1.09490194688533E-11 |
| Normal-vs-Age(81-100Yrs) |
2.530100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.472470E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.223500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.765800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.361600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.457200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.351800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.16027237501748E-12 |
| Normal-VS-Type2 PRCC |
2.10369999997795E-06 |
| Normal-VS-KIRP CIMP |
1.626032641866E-12 |
| Normal-VS-Unclassified PRCC |
2.47050000001803E-06 |
| Type1 PRCC-VS-Type2 PRCC |
5.111600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.76089999998275E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
6.583400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.18750000002821E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
9.231800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.0004999999591E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.16350000137311E-08 |
| Normal-vs-N1 |
1.24349999996998E-06 |
| Normal-vs-N2 |
5.30629999939691E-08 |
| N0-vs-N1 |
4.559800E-02 |
| N0-vs-N2 |
1.188580E-01 |
| N1-vs-N2 |
6.767000E-01 |
|
|
